Changing trends in carrier screening for genetic disease in the United States
- PMID: 26138560
- PMCID: PMC4758394
- DOI: 10.1002/pd.4647
Changing trends in carrier screening for genetic disease in the United States
Abstract
Genetic disease is the leading cause of infant death in the United States, accounting for approximately 20% of annual infant mortality. Advances in genomic medicine and technological platforms have made possible low cost, pan-ethnic expanded genetic screening that enables obstetric care providers to offer screening for over 100 recessive genetic diseases. However, the rapid integration of genomic medicine into routine obstetric practice has raised some concerns about the practical implementation of such testing. These changing trends in carrier screening, along with concerns and potential solutions, will be addressed.
© 2015 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd.
References
-
- Collins FS. The Language of Life: DNA and the Revolution in Personalized Medicine. (1st edn), New York: Harper, 2010;23–58.
-
- Kaback MM. Population‐based genetic screening for reproductive counseling: the Tay–Sachs disease model. Eur J Pediatr 2000;159(Suppl 3):S192–5. - PubMed
-
- American College of Obstetricians and Gynecologists Committee on Genetics . ACOG Committee Opinion No. 486: update on carrier screening for cystic fibrosis. Obstet Gynecol 2011;117(4):1028–31. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical